Geode Capital Management, LLC Nls Pharmaceutics Ltd. Transaction History
Geode Capital Management, LLC
- $1.07 Trillion
- Q1 2024
A detailed history of Geode Capital Management, LLC transactions in Nls Pharmaceutics Ltd. stock. As of the latest transaction made, Geode Capital Management, LLC holds 14,362 shares of NLSP stock, worth $2,872. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,362
Previous 14,362
-0.0%
Holding current value
$2,872
Previous $8,000
75.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NLSP
# of Institutions
9Shares Held
8.16MCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA5.75MShares$1.15 Million0.03% of portfolio
-
Armistice Capital, LLC New York, NY2.17MShares$434,4000.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny180KShares$35,9150.0% of portfolio
-
Xtx Topco LTD London, X025.6KShares$5,1180.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il19.2KShares$3,8360.0% of portfolio
About NLS Pharmaceutics Ltd.
- Ticker NLSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,349,900
- Market Cap $5.87M
- Description
- NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, suc...